A national registry for acute coronary syndromes will improve patient care and clinical results
Acute coronary syndromes (ACS) represent a substantial burden of morbidity and mortality within Australia.1 Modern treatment of these syndromes requires efficient risk stratification, timely angiography and revascularisation, and use of proven secondary prevention therapies.2-4 With a robust evidence base, it is a reasonable societal expectation that care be applied as completely as possible, to optimise recovery and secondary prevention. Clinical performance measures for ACS care have a central role in facilitating the translation of the evidence base into improved clinical outcomes.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. Heart, stroke and vascular diseases, Australian facts 2004. Canberra: AIHW, 2004. (AIHW Cat. No. CVD 27; Cardiovascular Disease Series No. 22.) http://www.aihw.gov.au/publication-detail/?id=6442467598 (accessed Jun 2012).
- 2. Aroney CN, Aylward P, Chew DP, et al. 2007 addendum to the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2008; 188: 302-303. <MJA full text>
- 3. Acute Coronary Syndromes Guidelines Working Group. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184 (8 Suppl): S1-S32.
- 4. Brieger D, Kelly AM, Aroney C, et al; National Heart Foundation ACS Implementation and Advocacy Working Group. Acute coronary syndromes: consensus recommendations for translating knowledge into action. Med J Aust 2009; 191: 334-338. <MJA full text>
- 5. National Health and Hospitals Reform Commission. A healthier future for all Australians. Final report. Canberra: Commonwealth of Australia, 2009. http://www.health.gov.au/internet/nhhrc/publishing.nsf/Content/nhhrc-report (accessed Jun 2012).
- 6. Chew DP, Amerena J, Coverdale S, et al. Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J 2007; 37: 741-748.
- 7. Chew DP, Amerena JV, Coverdale SG, et al; ACACIA Investigators. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. Med J Aust 2008; 188: 691-697. <MJA full text>
- 8. Walters DL, Aroney CN, Chew DP, et al. Variations in the application of cardiac care in Australia. Med J Aust 2008; 188: 218-223. <MJA full text>
- 9. Aliprandi-Costa B, Ranasinghe I, Chow V, et al. Management and outcomes of patients with acute coronary syndromes in Australia and New Zealand, 2000–2007. Med J Aust 2011; 195: 116-121. <MJA full text>
- 10. Chew DP, Huynh LT, Liew D, et al. Potential survival gains in the treatment of myocardial infarction. Heart 2009; 95: 1844-1850.
- 11. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006; 355: 2308-2320.
- 12. Eagle KA, Montoye CK, Riba AL, et al. Guideline-based standardized care is associated with substantially lower mortality in medicare patients with acute myocardial infarction: the American College of Cardiology’s Guidelines Applied in Practice (GAP) Projects in Michigan. J Am Coll Cardiol 2005; 46: 1242-1248.
- 13. Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 2011; 305: 1677-1684.
- 14. Cameron PA, Gabbe BJ, Cooper DJ, et al. A statewide system of trauma care in Victoria: effect on patient survival. Med J Aust 2008; 189: 546-550. <MJA full text>
- 15. Jakobsen E, Palshof T, Osterlind K, Pilegaard H. Data from a national lung cancer registry contributes to improve outcome and quality of surgery: Danish results. Eur J Cardiothorac Surg 2009; 35: 348-352.
- 16. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011. Canberra: AIHW, 2011. (AIHW Cat. No. CVD 53.) http://www.aihw.gov.au/publication-detail/?id=10737418510 (accessed Jun 2012).
- 17. Chew DP, Allan RM, Aroney CN, Sheerin NJ. National data elements for the clinical management of acute coronary syndromes. Med J Aust 2005; 182 (9 Suppl): S1-S14.
- 18. National Heart Foundation of Australia and Australian Healthcare and Hospitals Association. Better hospital care for Aboriginal and Torres Strait Islander people experiencing heart attack. Melbourne: National Heart Foundation, 2010. http://www.health.act.gov.au/health-services/aboriginal-torres-strait-islander/information/national-health-publications (accessed Jun 2012).
- 19. Australian Commission on Safety and Quality in Health Care. Australian Clinical Quality Registries. Canberra: ACSQHC, 2010. http://www.safetyandquality.gov.au/our-work/information-strategy/clinical-quality-registries/strategic-operating-principles-for-clinical-quality-registries (accessed Jun 2012).
- 20. Australian Institute of Health and Welfare. Towards national indicators of safety and quality in health care. Canberra: AIHW, 2009. (AIHW Cat. No. HSE 75.) http://www.aihw.gov.au/publication-detail/?id=6442468285 (accessed Jun 2012).
- 21. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction. Circulation 2008; 118: 2596-2648.
- 22. National Heart Foundation of Australia and National Stroke Foundation. Time for action: a national plan to reduce the burden of cardiovascular disease — Australia’s biggest killer. Melbourne: National Heart Foundation, 2008. http://www.health.gov.au/internet/nhhrc/publishing.nsf/Content/402/$FILE/402%20-%20NHHRC%20FINAL%20JUNE%206%202008.pdf (accessed Jun 2012).
Online responses are no longer available. Please refer to our instructions for authors page for more information.
We thank Colleen Bichel, Neville Board, Carrie Toohey, Karen Uhlmann and Jinty Wilson for contributions to and review of our article.
Derek Chew has served on advisory boards for AstraZeneca and Eli Lilly and has received consultancy fees for Flinders University from Abbott Vascular and payment for lectures from AstraZeneca. David Brieger has served on advisory boards for and has received payment for lectures from AstraZeneca, Boehringer-Ingelheim, Eli Lilly and Sanofi, and has received research grants to the University of Sydney from AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Sanofi and Merck.